Radiographic progression and remission rates in early rheumatoid arthritis–MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year …

…, T Ellingsen, H Lindegaard, J Pødenphant… - Annals of the …, 2010 - ard.bmj.com
Objective At 5 years' follow-up of early (<6 months) rheumatoid arthritis patients to (1) investigate
whether initial combination therapy with methotrexate (MTX) and ciclosporin (CSA) (n=…

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early …

…, A Svendsen, U Tarp, J Pødenphant… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To investigate whether disease control can be achieved in early active rheumatoid
arthritis (RA) by treatment with methotrexate and intraarticular betamethasone, and whether …

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and …

…, ML Hetland, P Junker, J Pødenphant… - Annals of the …, 2014 - ard.bmj.com
Objectives An investigator-initiated, double-blinded, placebo-controlled, treat-to-target protocol
(Clinical Trials: NCT00660647 ) studied whether adalimumab added to methotrexate and …

Short-and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area …

…, T Ellingsen, H Lindegaard, J Pødenphant… - Annals of the …, 2012 - ard.bmj.com
Objective To investigate the short-term and long-term efficacy of intra-articular betamethasone
injections, and the impact of joint area, repeated injections, MRI pathology, anticyclic …

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

E Hjardem, M Østergaard, J Pødenphant… - Annals of the …, 2007 - ard.bmj.com
Objective: To investigate the efficacy of switching to a second biological drug in rheumatoid
arthritis (RA) patients. Methods: Since 2000, Danish RA patients (n = 1021) receiving …

A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects

M Hansen, J Pødenphant, A Florescu… - Annals of the …, 1999 - ard.bmj.com
OBJECTIVES To study benefits and skeletal side effects of carefully monitored prednisolone
treatment in patients with active rheumatoid arthritis. METHODS One hundred and two …

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results …

…, HM Lindegaard, A Hansen, J Pødenphant… - Annals of the …, 2008 - ard.bmj.com
Background: Prescription practice for tumour necrosis factor α (TNFα) inhibitors has changed
towards treating patients with lower disease activity. Objective: To determine the trend in …

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis …

…, J Møller, P Junker, J Pødenphant… - Annals of the …, 2015 - ard.bmj.com
Objectives To investigate whether a treat-to-target strategy with methotrexate and intra-articular
glucocorticosteroid injections suppresses MRI inflammation and halts structural damage …

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc …

…, B Langdahl, B Zerahn, J Pødenphant… - Annals of the …, 2014 - ard.bmj.com
Objectives The aims of this study were to investigate the influence of alendronate and intra-articular
betamethasone treatment on bone mineral density (BMD) changes in hand, lumbar …

[HTML][HTML] CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients

…, P Junker, JS Johansen, J Pødenphant… - Arthritis Research & …, 2014 - Springer
Introduction Single-nucleotide polymorphisms (SNPs) in the CRP gene are implicated in the
regulation of the constitutional C-reactive protein (CRP) expression and its response to …